UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with...

22
UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2012

Transcript of UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with...

Page 1: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2012

Page 2: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.2. Funnel plot of percentage of haemodialysis patientswith phosphate within the range specified by the RA clinical

audit measure (1.1–1.7 mmol/L) by centre in 2012

Page 3: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.3. Percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2012

Page 4: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.4. Funnel plot of percentage of peritoneal dialysis patientswith phosphate within the range specified by the RA clinical audit

measure (1.1–1.7 mmol/L) by centre in 2012

Page 5: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.5. Longitudinal change in percentage of patients with phosphate below, within and above the

2010 RA standard by dialysis modality 2000–2012

Page 6: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.6. Percentage of haemodialysis patients with adjusted calcium

within range (2.2–2.5 mmol/L) by centre in 2012

Page 7: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.7. Funnel plot of percentage of haemodialysispatients with adjusted calcium within range (2.2–2.5

mmol/L)by centre in 2012

Page 8: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.8. Percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2012

Page 9: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.9. Funnel plot of percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2012

Page 10: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.10. Longitudinal change in percentage of patients with adjusted calcium <2.2 mmol/L, 2.2–2.5 mmol/L and

>2.5 mmol/L by dialysis modality 2002–2012

Page 11: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.11. Percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2012

Page 12: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.12. Funnel plot of percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2012

Page 13: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.13. Percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2012

Page 14: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.14. Funnel plot of percentage of peritoneal dialysispatients with PTH within range (16–72 pmol/L) by centre in 2012

Page 15: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.15. Percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2012

Page 16: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.16. Percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2012

Page 17: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.17. Funnel plot for percentage of HD patients achievingsimultaneous control of all three BMD parameters in preventing

severe hyperparathyroidism by centre in 2012

Page 18: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.18. Funnel plot for percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing

severe hyperparathyroidism by centre in 2012

Page 19: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.19. Funnel plot for percentage of haemodialysis patientswithin the range for bicarbonate (18–24 mmol/L) by centre in 2012

Page 20: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.20. Funnel plot for percentage of peritoneal dialysis patients within the range for bicarbonate (22–30 mmol/L) by centre in 2012

Page 21: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.21. Median total cholesterol in haemodialysis patients by centre in 2012

Page 22: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 16th Annual Report

Figure 12.22. Median total cholesterol in peritoneal dialysis patients by centre in 2012